secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001493152-25-018684
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio shareholders approve reverse stock split of 1:5 to 1:50, board to decide ratio
--------------------------------------------------------------------------------

- Three directors re-elected: J.D. Finley (647,086 votes for), Donald Williams (641,789), Emil Chuang (659,895); each had 2,849,169 broker non-votes.
- Baker Tilly ratified as auditor for FY2025 with 3,348,348 votes for, 108,424 against.
- Reverse stock split amendment approved 2,353,265 for to 1,122,616 against; board may set ratio 1:5 to 1:50, implement by Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/0001493152-25-018684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225018684/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer